Published Date: 8-Dec-2020
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Asia Pacific Medical Footwear Market, published by KBV research, the Asia Pacific Medical Footwear Market would witness market growth of 9.5% CAGR during the forecast period (2020-2026).
The China market dominated the Asia Pacific Medical Footwear Market by Country in 2019, and would continue to be a dominant market till 2026. The Japan market is experiencing a CAGR of 10.4% during (2020 - 2026). Additionally, The Australia market is poised to grow at a CAGR of 10% during (2020 - 2026).
The Offline market dominated the Australia Medical Footwear Market by Distribution Channel in 2019, growing at a CAGR of 9.9 % during the forecast period. The Online market is expected to witness a CAGR of 10.2% during (2020 - 2026).
The Men market dominated the Singapore Medical Footwear Market by End User in 2019, thereby, achieving a market value of $81.1 Million by 2026. The Women market is estimated to grow at a CAGR of 11.4% during (2020 - 2026).
Structural Insights: https://www.kbvresearch.com/asia-pacific-medical-footwear-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Stryker Corporation, Colfax Corporation (Dr. Comfort), Dr. Zen, Inc., Gravity Defyer Corporation, Duna Srl, Aetrx Worldwide, Inc., Drew Shoe Corporation, New Balance, Inc., Dr. Foot, Inc., and Podartis Srl.
By End User
By Distribution Channel
Unique Offerings from KBV Research